Status:
COMPLETED
Supportive Care Delivered by Telemedicine to Cancer Patients at Home
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Cancer
Supportive Care
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will test whether supportive care follow-up delivered to cancer patients at home by telemedicine ("virtual" medical visits using telecommunications technologies) is as effective as in-perso...
Detailed Description
The protocol was developed and initially implemented when the standard of care for Supportive Care (and oncology) follow-up at MSK was in-person visiting and home telemedicine was only in an early sta...
Eligibility Criteria
Inclusion
- age 18 years or older
- solid tumor of any type
- completed an initial in-person clinic visit (i.e. an IR/NV or AFX visit) at Rockefeller Outpatient Pavilion with Dr. Saldivar, Dr. Martin, Supportive Care physicians, or Andrea Dolan, a Supportive Care nurse practitioner
- planned for Supportive Care Service follow-up visits, but none yet completed
- enrolled on the MyMSK secure online patient portal and have access to the portal off site of MSK campuses
- resident of New York or New Jersey or Connecticut (clinicians may not be licensed in other states, as would be required for televisits to patients there)
Exclusion
- Patients and informal caregivers who cannot communicate with clinicians/respond to instruments in English without the use of an interpreter
Key Trial Info
Start Date :
October 24 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 3 2025
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT04136340
Start Date
October 24 2019
End Date
July 3 2025
Last Update
July 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065